Targeting Peroxisome Proliferator Activated Receptor α (PPAR α) for the Prevention of Mitochondrial Impairment and Hypertrophy in Cardiomyocytes
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
Targeting Peroxisome Proliferator Activated Receptor α (PPAR α) for the Prevention of Mitochondrial Impairment and Hypertrophy in Cardiomyocytes ; volume:49 ; number:1 ; year:2018 ; pages:245-259
Cellular physiology and biochemistry ; 49, Heft 1 (2018), 245-259
- Urheber
-
Kar, Dipak
Bandyopadhyay, Arun
- DOI
-
10.1159/000492875
- URN
-
urn:nbn:de:101:1-2018091300542430510499
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:22 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Kar, Dipak
- Bandyopadhyay, Arun
Ähnliche Objekte (12)
Modulation inflammatorischer Arteriosklerosemarker durch Peroxisome proliferator-activated receptor-alpha (PPAR alpha)- aktivierende Fibratderivate
Dual and pan-peroxisome proliferator-activated receptors (PPAR) co-agonism: the bezafibrate lessons
It takes two peroxisome proliferator-activated receptors (PPAR-β/δ and PPAR-γ) to tango idiopathic pulmonary fibrosis
Peroxisome proliferator-activated receptor (PPAR)-aktivierende Angiotensin-Typ 1-Rezeptorblocker bei Adipositas und Insulinresistenz
Modulation inflammatorischer Atherosklerosemarker durch Peroxisome proliferator-activated receptor-alpha (PPARα)]-aktivierendes [(PPAR-alpha)-aktivierendes] Fenofibrat
![Estrogen improves vascular function via peroxisome-proliferator-activated-receptor-γ [peroxisome-proliferator-activated-receptor-gamma]](/assets/placeholder/searchResultMediaNoDigitisedMedia.png)
Estrogen improves vascular function via peroxisome-proliferator-activated-receptor-γ [peroxisome-proliferator-activated-receptor-gamma]
Assoziation des Prolin-12-Alanin-Polymorphismus im Peroxisome-Proliferator-activated-receptor-γ- [Peroxisome-Proliferator-activated-receptor-gamma-] (PPARγ)-Gen [(PPAR-gamma)-Gen] mit Diabetes mellitus Typ 2, Adipositas und Dyslipoproteinämien
In vitro characterization of telmisartan derived compounds for selective peroxisome proliferator activated receptor gamma (PPAR-y) [(PPARgamma)] modulation
Role of peroxisome proliferator activated receptor α [alpha] (PPARα) [PPAR-alpha] in cardiomyogenesis of mouse embryonic stem cells
Different skeletal effects of the peroxisome proliferator activated receptor (PPAR)α agonist fenofibrate and the PPARγ agonist pioglitazone
The peroxisome proliferator-activated receptor (PPAR) alpha agonist fenofibrate maintains bone mass, while the PPAR gamma agonist pioglitazone exaggerates bone loss, in ovariectomized rats
Peroxisome proliferator-activated receptors (PPARs) und die Lymphozytenmigration
Modulation inflammatorischer Arteriosklerosemarker durch Peroxisome proliferator-activated receptor-alpha (PPAR alpha)- aktivierende Fibratderivate
Dual and pan-peroxisome proliferator-activated receptors (PPAR) co-agonism: the bezafibrate lessons
It takes two peroxisome proliferator-activated receptors (PPAR-β/δ and PPAR-γ) to tango idiopathic pulmonary fibrosis
Peroxisome proliferator-activated receptor (PPAR)-aktivierende Angiotensin-Typ 1-Rezeptorblocker bei Adipositas und Insulinresistenz
Modulation inflammatorischer Atherosklerosemarker durch Peroxisome proliferator-activated receptor-alpha (PPARα)]-aktivierendes [(PPAR-alpha)-aktivierendes] Fenofibrat
Estrogen improves vascular function via peroxisome-proliferator-activated-receptor-γ [peroxisome-proliferator-activated-receptor-gamma]
Assoziation des Prolin-12-Alanin-Polymorphismus im Peroxisome-Proliferator-activated-receptor-γ- [Peroxisome-Proliferator-activated-receptor-gamma-] (PPARγ)-Gen [(PPAR-gamma)-Gen] mit Diabetes mellitus Typ 2, Adipositas und Dyslipoproteinämien
In vitro characterization of telmisartan derived compounds for selective peroxisome proliferator activated receptor gamma (PPAR-y) [(PPARgamma)] modulation
Role of peroxisome proliferator activated receptor α [alpha] (PPARα) [PPAR-alpha] in cardiomyogenesis of mouse embryonic stem cells
Different skeletal effects of the peroxisome proliferator activated receptor (PPAR)α agonist fenofibrate and the PPARγ agonist pioglitazone
The peroxisome proliferator-activated receptor (PPAR) alpha agonist fenofibrate maintains bone mass, while the PPAR gamma agonist pioglitazone exaggerates bone loss, in ovariectomized rats
Peroxisome proliferator-activated receptors (PPARs) und die Lymphozytenmigration
Modulation inflammatorischer Arteriosklerosemarker durch Peroxisome proliferator-activated receptor-alpha (PPAR alpha)- aktivierende Fibratderivate
Dual and pan-peroxisome proliferator-activated receptors (PPAR) co-agonism: the bezafibrate lessons
It takes two peroxisome proliferator-activated receptors (PPAR-β/δ and PPAR-γ) to tango idiopathic pulmonary fibrosis
Peroxisome proliferator-activated receptor (PPAR)-aktivierende Angiotensin-Typ 1-Rezeptorblocker bei Adipositas und Insulinresistenz
Modulation inflammatorischer Atherosklerosemarker durch Peroxisome proliferator-activated receptor-alpha (PPARα)]-aktivierendes [(PPAR-alpha)-aktivierendes] Fenofibrat
Estrogen improves vascular function via peroxisome-proliferator-activated-receptor-γ [peroxisome-proliferator-activated-receptor-gamma]
Assoziation des Prolin-12-Alanin-Polymorphismus im Peroxisome-Proliferator-activated-receptor-γ- [Peroxisome-Proliferator-activated-receptor-gamma-] (PPARγ)-Gen [(PPAR-gamma)-Gen] mit Diabetes mellitus Typ 2, Adipositas und Dyslipoproteinämien
In vitro characterization of telmisartan derived compounds for selective peroxisome proliferator activated receptor gamma (PPAR-y) [(PPARgamma)] modulation
Role of peroxisome proliferator activated receptor α [alpha] (PPARα) [PPAR-alpha] in cardiomyogenesis of mouse embryonic stem cells
Different skeletal effects of the peroxisome proliferator activated receptor (PPAR)α agonist fenofibrate and the PPARγ agonist pioglitazone
The peroxisome proliferator-activated receptor (PPAR) alpha agonist fenofibrate maintains bone mass, while the PPAR gamma agonist pioglitazone exaggerates bone loss, in ovariectomized rats